Table 3. Clinical outcome in 14... | American Society of Hematology

Table 3.

Clinical outcome in 14 HIV-infected patients with MCD and NHL

Patient	Staging	WBC × 10⁶/L	Hb g/dL	Platelets × 10⁹/L	Therapy	Response	Outcome
1	Pleura	2 300	8.5	124	VP16	Failure	Death wk 3
2	Pericardium	3 200	7.8	154	ACVBP	PR	Death mo 7
3	Pleura, peritoneum	10 800	10.6	565	CHOP-MTX	CR	Alive wk 5
4	Skin, BM, GI, CNS	6 900	8.3	413	EDX-VP16	PR	Death mo 5
5	Cerebral	7 800	13.4	265	Steroids	Failure	Death wk 3
6	Rectal	3 200	12	187	ACVBP	CR	Alive mo 25
7	GI, BM	2 500	7.8	35	Low-dose CHOP	Failure	Death wk 7
8	GI, pleura, peritoneum	9 000	11.7	854	CHOP-MTX	Failure	Death wk 3
9	Nodal	15 800	17	34	None	Progression	Death wk 1
10	Blood, spleen, GI	12 500	8.2	68	None	Progression	Death wk 1
11	Blood	15 600	9.9	154	None	Progression	Death wk 1
12	Blood	38 000	8.5	228	None	Progression	Death wk 1
13	Blood	22 600	7.1	12	None	Progression	Death wk 1
14	Nodal, spleen	7 500	10.8	82	None	Progression	Death wk 2

Patient	Staging	WBC × 10⁶/L	Hb g/dL	Platelets × 10⁹/L	Therapy	Response	Outcome
1	Pleura	2 300	8.5	124	VP16	Failure	Death wk 3
2	Pericardium	3 200	7.8	154	ACVBP	PR	Death mo 7
3	Pleura, peritoneum	10 800	10.6	565	CHOP-MTX	CR	Alive wk 5
4	Skin, BM, GI, CNS	6 900	8.3	413	EDX-VP16	PR	Death mo 5
5	Cerebral	7 800	13.4	265	Steroids	Failure	Death wk 3
6	Rectal	3 200	12	187	ACVBP	CR	Alive mo 25
7	GI, BM	2 500	7.8	35	Low-dose CHOP	Failure	Death wk 7
8	GI, pleura, peritoneum	9 000	11.7	854	CHOP-MTX	Failure	Death wk 3
9	Nodal	15 800	17	34	None	Progression	Death wk 1
10	Blood, spleen, GI	12 500	8.2	68	None	Progression	Death wk 1
11	Blood	15 600	9.9	154	None	Progression	Death wk 1
12	Blood	38 000	8.5	228	None	Progression	Death wk 1
13	Blood	22 600	7.1	12	None	Progression	Death wk 1
14	Nodal, spleen	7 500	10.8	82	None	Progression	Death wk 2

Hb indicates hemoglobin; BM, bone marrow; GI, gastrointestinal tract; CNS, central nervous system; PR, partial response; and CR, complete remission.